*Quantitative Imaging Cytometry Center of Excellence* *Quantitative Imaging Cytometry Symposium* *Boston, Massachusetts* August 10 – 12, 2010** Symposium Registration
MORNING SESSIONS
Tuesday, August 10, 2010 Quantitative Imaging Cytometry as a Cutting-Edge Research Tool Enders Auditorium, Children's Hospital Boston Chairs: Leslie Silberstein, Children's Hospital Boston and William Telford, NIH
08.00 – 9.00	*Registration*
09.00 – 9.15	*Welcome* – Leslie Silberstein, MD, Director, Joint Program in Transfusion Medicine, Children's Hospital Boston, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
09.15 – 9.55	Imaging Cytometry: An Expanding Role in Biomedical Imaging Analysis – William Telford, PhD, Director, Flow Cytometry Core Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD
09.55 – 10.35	Spatial Analysis of Hematopoietic Stem and Progenitor Cells in Bone Marrow – Leslie Silberstein, MD, Director, Joint Program in Transfusion Medicine, Children's Hospital Boston, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
10.35 – 10.45	*Break*
10.45 – 11.25	Combinatorial Development of Biomaterials for Tissue Engineering and Drug Delivery – Daniel Anderson, PhD, Senior Research Associate, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
11.25 – 12.05	The iCys^® Imaging Cytometer in the Epigenetic Toolbox for Autism Research - Janine LaSalle, PhD, Professor, Medical Microbiology and Immunology, UC Davis School of Medicine, Davis, CA.
12.05 – 12.15	*Discussion*
Wednesday, August 11, 2010 Advanced Cell Cycle and DNA Damage Analysis Jimmy Fund Auditorium, Dana-Farber Cancer Center Chair: Michael Fenech, CSIRO, Adelaide, Australia
09.00 – 9.30	*Assessment of DNA Damage by High-Resolution Cytometry* – Zbigniew Darzynkiewicz, MD, PhD, Director, Brander Cancer Research Institute, Valhalla, NY
09.30 – 10.00	*Advanced Cell Cycle Analysis –* James Jacobberger, PhD, Professor of Oncology, Case Western Reserve University, and Director, Cell Analysis Core, Case Comprehensive Cancer Center, Cleveland OH
10.00 – 10.15	*Break*
10.15 – 10.45	The Untapped Potential of Laser Scanning Cytometry in Genome Damage, Proteome and Nutritional Diagnostics at the Single Cell and Sub-Type Level - Michael Fenech, PhD, Principal Research Scientist, CSIRO Food and Nutrition Sciences, Commonwealth Scientific and Industrial Research Organisation, Adelaide, Australia
10.45 – 11.15	Potential Mechanisms for the Generation of Chromosome Aneuploidy in Human Cancer - John M. Lehman, PhD, Brody School of Medicine, East Carolina University, Greenville, NC
11.15 – 11.45	Practical Apoptosis Assays Using the iCyte^® Platform - Stephan Ruetz, PhD, Laboratory Head, Oncology Research, Novartis Institute for Biomedical Research, Basel, Switzerland
11.45 – 12.00	*Discussion*
Thursday, August 12, 2010 Pharmacodynamic and Diagnostic Tissue-Based Biomarkers Jimmy Fund Auditorium, Dana-Farber Cancer Center Chair: Shazib Pervaiz, National University of Singapore and Duke-NUS GMS
09.00 – 9.30	Application of Imaging Cytometry to the Molecular Therapeutics of Human Solid Tumors - David Hedley, MD, Senior Scientist, Senior Scientist, Division of Applied Molecular Oncology, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
09.30 – 10.00	Leveraging Quantitative Imaging Cytometry to Measure the Pharmacodynamic Impact of Drugs in Development - Gloria Juan, PhD, Principal Scientist, Clinical Immunology, Amgen, Thousand Oaks, CA
10.00 – 10.15	*Break*
10.00 – 10.45	Quantitative Imaging Cytometry for the Diagnostic Pathologist: What Does the Laser Scatter Imaging Component Add? - William Geddie, MD, Cytopathologist, University Health Network/Toronto General Hospital, Toronto ON, Canada
10.00 – 11.15	Mislocation of APAFI as a Novel Diagnostic and Prognostic Marker for Refractory Diffuse B-Cell Lymphoma? - Shazib Pervaiz, National University of Singapore and Duke-NUS GMS
10.00 – 11.45	Capturing Signaling Events in the Immune System in Situ - Margaret Harnett, PhD, Glasgow Biomedical Research Centre, University of Glasgow, Scotland, UK
10.00 – 12.00	Discussion
AFTERNOON WORKSHOPS Karp and CLSB Buildings, Children's Hospital Boston Participants will have their choice of three of the workshops listed below
*Workshop I*		*Cytome Diagnostics* Wayne Leifert, PhD and Maxime Francois, CSIRO Food and Nutrition Sciences Adelaide, Australia
*Workshop II*		*Quantitative Assessment of Pancreatic Islets* David Krull, GlaxoSmithKline Research Triangle Park, NC
*Workshop III*		*Advanced Cell Cycle Analysis* James Jacobberger, PhD and Tammy Stefan Case Comprehensive Cancer Center, Cleveland, OH
*Workshop IV*		*Immunophenotyping in FNAs (fine needle aspirates)* William Geddie, MD, UHN/Toronto General Hospital Toronto, ON, Canada
*Workshop V*		*Analysis of Drug-Induced DNA Damage* Zbigniew Darzynkiewicz, MD, PhD, Director, Brander Cancer Research Institute, New York Medical College, Valhalla, NY and Shazib Pervaiz, National University of Singapore and Duke-NUS GMS
*Workshop VI*		*Quantitative Imaging of Bone Marrow Microenvironment* César Nombela-Arrieta, PhD and Shin-Young Park, PhD Children’s Hospital Boston, Boston, MA
Evenings provide a relaxed setting for socializing. The opening reception and poster session will be held on Tuesday, August 10 at 5:30, in the Karp Family Research Building (10th Floor Atrium). Information about getting to Boston, accommodations for the meeting, and the things to see and do in the area is available here.
REGISTRATION and DEADLINES
Registration for full program ends July 20, 2010 Registration for mornings only ends August 5, 2010
Call for short oral and poster presentations: Short oral presentations: March 10, 2010 Poster Presentation: Deadline July 20, 2010

Symposium Registration

MORNING SESSIONS

Tuesday, August 10, 2010

Imaging Cytometry: An Expanding Role in Biomedical Imaging Analysis – William Telford, PhD, Director, Flow Cytometry Core Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD

Combinatorial Development of Biomaterials for Tissue Engineering and Drug Delivery – Daniel Anderson, PhD, Senior Research Associate, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA

The iCys® Imaging Cytometer in the Epigenetic Toolbox for Autism Research - Janine LaSalle, PhD, Professor, Medical Microbiology and Immunology, UC Davis School of Medicine, Davis, CA.

Wednesday, August 11, 2010

Potential Mechanisms for the Generation of Chromosome Aneuploidy in Human Cancer - John M. Lehman, PhD, Brody School of Medicine, East Carolina University, Greenville, NC

Practical Apoptosis Assays Using the iCyte® Platform - Stephan Ruetz, PhD, Laboratory Head, Oncology Research, Novartis Institute for Biomedical Research, Basel, Switzerland

Discussion

Thursday, August 12, 2010

Application of Imaging Cytometry to the Molecular Therapeutics of Human Solid Tumors - David Hedley, MD, Senior Scientist, Senior Scientist, Division of Applied Molecular Oncology, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada

Leveraging Quantitative Imaging Cytometry to Measure the Pharmacodynamic Impact of Drugs in Development - Gloria Juan, PhD, Principal Scientist, Clinical Immunology, Amgen, Thousand Oaks, CA

Quantitative Imaging Cytometry for the Diagnostic Pathologist: What Does the Laser Scatter Imaging Component Add? - William Geddie, MD, Cytopathologist, University Health Network/Toronto General Hospital, Toronto ON, Canada

Mislocation of APAFI as a Novel Diagnostic and Prognostic Marker for Refractory Diffuse B-Cell Lymphoma? - Shazib Pervaiz, National University of Singapore and Duke-NUS GMS

Capturing Signaling Events in the Immune System in Situ - Margaret Harnett, PhD, Glasgow Biomedical Research Centre, University of Glasgow, Scotland, UK

Discussion

Combinatorial Development of Biomaterials for Tissue Engineering and Drug Delivery –
Daniel Anderson, PhD, Senior Research Associate, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA

The iCys^® Imaging Cytometer in the Epigenetic Toolbox for Autism Research - Janine LaSalle, PhD, Professor, Medical Microbiology and Immunology, UC Davis School of Medicine, Davis, CA.

Potential Mechanisms for the Generation of Chromosome Aneuploidy in Human Cancer -
John M. Lehman, PhD, Brody School of Medicine, East Carolina University, Greenville, NC

Practical Apoptosis Assays Using the iCyte^® Platform - Stephan Ruetz, PhD, Laboratory Head, Oncology Research, Novartis Institute for Biomedical Research, Basel, Switzerland

Application of Imaging Cytometry to the Molecular Therapeutics of Human Solid Tumors -
David Hedley, MD, Senior Scientist, Senior Scientist, Division of Applied Molecular Oncology,
Ontario Cancer Institute, University Health Network, Toronto, ON, Canada